Our Investors Support Bold Initiatives

Investor Event at the 2017 San Antonio Breast Cancer Symposium

On December 6, 2017, Immunomedics hosted an investor event at the Grand Hyatt Hotel in San Antonio, TX. Click the link below to access the webcast.

Sign up for the Latest Information from Immunomedics

Annual Report

Immunomedics is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer, autoimmune disorders and other serious diseases.

icon of page with pie chart on it

Explore Resources for Current and Prospective Investors.

Explore Resources